1. Home
  2. RDWR vs KURA Comparison

RDWR vs KURA Comparison

Compare RDWR & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$29.99

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

SELL

Current Price

$10.66

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RDWR
KURA
Founded
1996
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
RDWR
KURA
Price
$29.99
$10.66
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$30.50
★ $31.85
AVG Volume (30 Days)
254.7K
★ 1.6M
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $67,482,000.00
Revenue This Year
$10.09
$42.46
Revenue Next Year
$7.92
$116.75
P/E Ratio
$59.76
★ N/A
Revenue Growth
N/A
★ 25.24
52 Week Low
$21.68
$7.36
52 Week High
$32.79
$13.90

Technical Indicators

Market Signals
Indicator
RDWR
KURA
Relative Strength Index (RSI) 54.23 40.35
Support Level $26.61 $8.45
Resistance Level $32.14 $12.21
Average True Range (ATR) 1.13 0.50
MACD 0.06 -0.09
Stochastic Oscillator 46.56 19.37

Price Performance

Historical Comparison
RDWR
KURA

About RDWR Radware Ltd.

Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: